CD44 and metastatic colorectal cancer: Recently, it was shown that in CTC of NSCLC patients the CD44(+)/CD24(−) population possess epithelial–mesenchymal transition characteristics [42], while another study in metastatic colorectal cancer has shown the prognostic significance of CTC that express both EMT and stem-like genes [22].